DalsnaFinance

Haisco licenses two drug candidates to Nuvectis for $40m upfront

Markets Investing.com By Investing.com 23 Jun 2026 13:34 1 min read
Haisco licenses two drug candidates to Nuvectis for $40m upfront

Haisco licenses two drug candidates to Nuvectis for $40m upfront

Haisco licenses two drug candidates to Nuvectis for $40m upfront

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.